Beetroot juice could ease dangerous lung clot complications
NCT ID NCT07431229
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether beetroot juice, which contains natural nitrates that relax blood vessels, can safely lower lung blood pressure in people with intermediate high-risk pulmonary embolism. 36 adult patients will receive either beetroot juice or a placebo for five days, alongside standard care. The main goal is to measure changes in lung artery pressure three hours after the first dose.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
nitrate-rich beetroot juice
What this could lead to
If it works, this could point toward a simple dietary supplement to stabilize patients with dangerous lung blood clots.
What could go wrong
This is a very small, early safety study with only 36 participants. It may show no benefit, and the juice could cause low blood pressure in some patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
South hospital Stockholm
RECRUITINGStockholm, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Stockholm, Sweden
NOT_YET_RECRUITINGStockholm, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact